EN
首页 资讯 期刊 导师 问答 求职 发Paper 文献直达 高级搜索 期刊列表
当前位置： X-MOL 学术 › Arthritis Res. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expression
Arthritis Research & Therapy ( IF 4.9 ) Pub Date : 2024-01-22 , DOI: 10.1186/s13075-024-03268-y
Lichong Shen , Hanlin Yin , Li Sun , Zhiliang Zhang , Yuyang Jin , Shan Cao , Qiong Fu , Chaofan Fan , Chunde Bao , Liangjing Lu , Yifan Zhan , Xiaojiang Xu , Xiaoxiang Chen , Qingran Yan

Correction: Arthritis Res Ther 25, 151 (2023)

https://doi.org/10.1186/s13075-023-03135-2

Following publication of the original article [1], the authors reported an error found in the Funding section, the grant number for Shanghai Municipal Commission of Health and Family Planning is incorrect. This should be corrected from “20204Y0088” to “20204Y0090”.

The original article [1] has been updated.

  1. Shen L, Yin H, Sun L, et al. Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression. Arthritis Res Ther. 2023;25:151. https://doi.org/10.1186/s13075-023-03135-2.

    Article CAS PubMed PubMed Central Google Scholar

Download references

Author notes

  1. Lichong Shen, Hanlin Yin, and Li Sun contributed equally.

  2. Xiaojiang Xu, Xiaoxiang Chen, and Qingran Yan contributed equally.

Authors and Affiliations

  1. Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China

    Lichong Shen, Hanlin Yin, Yuyang Jin, Shan Cao, Qiong Fu, Chaofan Fan, Chunde Bao, Liangjing Lu, Xiaoxiang Chen & Qingran Yan

  2. Department of Rheumatology and Immunology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China

    Li Sun

  3. Department of Plastic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China

    Zhiliang Zhang

  4. Department of Drug Discovery, Shanghai Huaota Biopharm, Shanghai, 201203, China

    Yifan Zhan

  5. Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA

    Xiaojiang Xu

  6. Department of Rheumatology, Nantong First People’s Hospital, Affiliated Hospital 2 of Nantong Universuty, Nantong Hospital of Renji Hospital Affiliated to Shanghai Jiao Tong Universuty School of Medicine, Nantong, 226006, China

    Xiaoxiang Chen

Authors
  1. Lichong ShenView author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanlin YinView author publications

    You can also search for this author in PubMed Google Scholar

  3. Li SunView author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhiliang ZhangView author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuyang JinView author publications

    You can also search for this author in PubMed Google Scholar

  6. Shan CaoView author publications

    You can also search for this author in PubMed Google Scholar

  7. Qiong FuView author publications

    You can also search for this author in PubMed Google Scholar

  8. Chaofan FanView author publications

    You can also search for this author in PubMed Google Scholar

  9. Chunde BaoView author publications

    You can also search for this author in PubMed Google Scholar

  10. Liangjing LuView author publications

    You can also search for this author in PubMed Google Scholar

  11. Yifan ZhanView author publications

    You can also search for this author in PubMed Google Scholar

  12. Xiaojiang XuView author publications

    You can also search for this author in PubMed Google Scholar

  13. Xiaoxiang ChenView author publications

    You can also search for this author in PubMed Google Scholar

  14. Qingran YanView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xiaojiang Xu, Xiaoxiang Chen or Qingran Yan.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, L., Yin, H., Sun, L. et al. Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expression. Arthritis Res Ther 26, 34 (2024). https://doi.org/10.1186/s13075-024-03268-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13075-024-03268-y

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative



中文翻译：
更正：艾拉莫德通过靶向早期生长反应 1 表达来减轻系统性硬化症中的纤维化

更正：关节炎研究 25, 151 (2023)

https://doi.org/10.1186/s13075-023-03135-2

原文章[1]发表后，作者报告资助部分发现错误，上海市卫生和计划生育委员会的资助编号不正确。应将其从“20204Y0088”更正为“ 20204Y0090 ”。

原文章[1]已更新。

  1. 沉L，尹H，孙L，等。艾拉莫德通过靶向早期生长反应 1 表达来减轻系统性硬化症中的纤维化。关节炎研究。2023；25：151。https://doi.org/10.1186/s13075-023-03135-2。

    文章 CAS PubMed PubMed Central Google Scholar

下载参考资料

作者笔记

  1. 沉力冲、尹翰林和孙力的贡献相等。

  2. 徐晓江、陈晓翔和颜清然的贡献相等。

作者和单位

  1. 上海交通大学医学院附属仁济医院风湿科，上海 200001

    沉力冲、尹翰林、金宇洋、曹山、付琼、范超凡、鲍春德、路良静、陈潇湘、严清然

  2. 温州医科大学第一附属医院风湿免疫科, 温州, 325000

    李孙

  3. 上海交通大学医学院附属仁济医院整形外科，上海 200001

    张志良

  4. 上海华塔生物制药药物研发部, 上海 201203

    詹一凡

  5. 杜兰大学医学院病理学和实验医学系，美国路易斯安那州新奥尔良

    徐晓江

  6. 南通市第一人民医院、南通大学第二附属医院、上海交通大学医学院附属仁济医院南通医院风湿科, 南通 226006

    陈潇湘

作者
  1. 沉力冲查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  2. 尹翰林查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  3. 李孙查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  4. 张志良查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  5. 金宇阳查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  6. 曹山查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  7. 付琼查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  8. 范超凡查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  9. 鲍春德查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  10. 陆良静查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  11. 詹一凡查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  12. 徐晓江查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  13. 陈潇湘查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

  14. 颜清然查看作者出版物

    您也可以在PubMed Google Scholar中搜索该作者 

通讯作者

通讯作者：徐晓江、陈晓翔或严清然。

开放获取本文根据知识共享署名 4.0 国际许可证获得许可，该许可证允许以任何媒介或格式使用、共享、改编、分发和复制，只要您对原作者和来源给予适当的认可，提供知识共享许可的链接，并指出是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可中，除非材料的出处中另有说明。如果文章的知识共享许可中未包含材料，并且您的预期用途不受法律法规允许或超出了允许的用途，则您需要直接获得版权所有者的许可。要查看此许可证的副本，请访问 http://creativecommons.org/licenses/by/4.0/。知识共享公共领域奉献豁免 (http://creativecommons.org/publicdomain/zero/1.0/) 适用于本文中提供的数据，除非数据的信用额度中另有说明。

转载和许可

检查更新。 通过 CrossMark 验证货币和真实性

引用这篇文章

沉L.，尹H.，孙L.等。更正：艾拉莫德通过靶向早期生长反应 1 表达来减轻系统性硬化症中的纤维化。关节炎研究 26 , 34 (2024)。https://doi.org/10.1186/s13075-024-03268-y

下载引文

  • 发表：

  • DOI ：https://doi.org/10.1186/s13075-024-03268-y

分享此文章

您与之分享以下链接的任何人都可以阅读此内容：

抱歉，本文目前没有可共享的链接。

由 Springer Nature SharedIt 内容共享计划提供
更新日期：2024-01-22
  点击分享   查看原文
点击收藏
公开下载
阅读更多本刊最新论文 本刊介绍/投稿指南
down
wechat
bug